Cargando…

Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Detalles Bibliográficos
Autores principales:	Riches, Marcie L., Hill, Joshua A., Martens, Michael, Auletta, Jeffery James, Baluch, Aliyah, Bhavsar, Kavita, Brown, Janice (Wes), Dhodapkar, Madhav Vishnu, DiFronzo, Nancy, Howard, Alan, Ibrahim, Uroosa, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Sharon, Elad, Spahn, Ashley, Toor, Amir A., Waldvogel, Stephanie, Westervelt, Peter, Young, Jo-Anne H., Perales, Miguel-Angel, Horowitz, Mary M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:	Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930030/ http://dx.doi.org/10.1016/S2666-6367(22)00635-2

Ejemplares similares

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2023)

COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Bhatt, Neel S., et al.
Publicado: (2021)

Humoral Response to COVID-19 Vaccination Given Pre-Cellular Therapy Wanes in Patients after Cellular Therapy: An Argument for Full Reimmunization
por: Shah, Gunjan L., et al.
Publicado: (2022)

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
por: Hill, Joshua A., et al.
Publicado: (2023)

Clinical Presentation and Outcomes of COVID-19 Following Hematopoietic Cell Transplantation
por: Camargo, Jose F., et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Hematopoietic Stem Cell Transplantation (HSCT) and Immune Effector Cell (IEC) Therapies: A Large US Cancer Center Experience
por: Maurer, Katie, et al.
Publicado: (2021)

Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19
por: Vasileiou, Spyridoula, et al.
Publicado: (2021)

A Portrait of Sars-Cov-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature
por: Bailey, Adrian, et al.
Publicado: (2022)

Efficacy of Sars-Cov-2 Vaccine in Hematopoietic Stem Cell Transplantation and CAR-T Cell Therapy Patients; A Single Study Experience
por: Zhuang, Eric, et al.
Publicado: (2022)

Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic
por: Spallone, Amy, et al.
Publicado: (2022)

Vaccination Against Sars-Cov-2 Induces Robust Humoral Immune Response in Patients with Previous Hematologic Stem Cell Transplantation
por: Roldan, Elisa, et al.
Publicado: (2022)

Outcomes of COVID-19 Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients Treated with Hyperbaric Oxygen: A Case Series
por: Usman, Shireen, et al.
Publicado: (2022)

Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease
por: Graham, Rudi-Ann Tamara, et al.
Publicado: (2022)

Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection
por: Faisal, Muhammad Salman, et al.
Publicado: (2022)

Response to Vaccination with Sars-CoV2 Vaccines in Patients Post Allogeneic Hematopoietic Cell Transplantation
por: Pabst, Caroline, et al.
Publicado: (2022)

Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System
por: Chu, Yaya, et al.
Publicado: (2023)

Efficacy of Tixagevimab-Cilgavimab in Preventing Sars-Cov-2 in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients
por: McGann, Mary, et al.
Publicado: (2023)

Stool Screening for Sars-Cov-2 RNA for COVID-19 in Patients Undergoing Hematopoietic Cell Transplantation, Cellular Therapy, and Induction Chemotherapy
por: Severyn, Christopher J., et al.
Publicado: (2023)

‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies
por: Sannareddy, Aishwarya, et al.
Publicado: (2023)

Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
por: Marinos, Alejandro, et al.
Publicado: (2023)

Evusheld™ Pre-Exposure COVID-19 Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant (HSCT) and Cellular Therapy Recipients: A Single Institution Retrospective Series
por: DePriest, Brittany Paige, et al.
Publicado: (2023)

Immunogenicity and Safety of a Heterologous COVID-19 Vaccine Regimen in Hematopoietic Stem Cell Transplant Recipients
por: Fatobene, Giancarlo, et al.
Publicado: (2023)

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2023)

COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort
por: Moreb, Jan S., et al.
Publicado: (2023)

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202
por: Lai, Tsung-Po, et al.
Publicado: (2022)

COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Sharma, Akshay, et al.
Publicado: (2021)

Severity, Course, and Predictors of Sleep Disruption Following Hematopoietic Cell Transplantation: A Secondary Data Analysis from the BMT CTN 0902 Trial
por: Jim, Heather S.L., et al.
Publicado: (2018)

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial
por: Shindiapina, Polina, et al.
Publicado: (2021)

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial
por: Malek, Ehsan, et al.
Publicado: (2023)

Incidence and Impact of Community Respiratory Viral Infection (CRV) in Haploidentical and Matched Sibling Donors Receiving Post-Transplant Cyclophosphamide (PTCy): A CIBMTR Analysis
por: Taplitz, Randy, et al.
Publicado: (2020)

Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
por: Dispenzieri, Angela, et al.
Publicado: (2022)

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study
por: Maziarz, Richard T., et al.
Publicado: (2016)

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
por: Chung, David J., et al.
Publicado: (2023)

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR(®) analysis
por: Williams, Kirsten M., et al.
Publicado: (2016)

NMDP/CIBMTR donor selection guidelines
Publicado: (2019)

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801
por: Carpenter, Paul A., et al.
Publicado: (2018)

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis
por: Riches, Marcie L., et al.
Publicado: (2015)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

BMT for Myelodysplastic Syndrome: When and Where and How
por: Jain, Akriti G., et al.
Publicado: (2022)

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
por: Dehn, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cmfg0brb6gtbk1g6cb0rea4l11